Literature DB >> 9660957

Polynucleotide ligase activity of eukaryotic topoisomerase I.

S Shuman1.   

Abstract

Introduction of a single ribonucleoside immediately 5' of the scissile phosphate of a duplex DNA substrate converts eukaryotic topoisomerase I into an endoribonuclease. Here, I demonstrate that the RNase reaction is reversible. Vaccinia topoisomerase can ligate 2', 3'-cyclic phosphate and 5'-hydroxyl termini annealed to a bridging template strand. Remarkably, the ligase activity of topoisomerase does not require the active site tyrosine, implying that strand joining can occur via direct attack of the 5' hydroxyl on the cyclic phosphate without a covalent intermediate. Ligation does require other catalytic side chains on the enzyme. These findings underscore how a common ancestral mechanism of phosphoryl and nucleotidyl transfer can be harnessed to perform seemingly diverse tasks through subtle changes at the active site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660957     DOI: 10.1016/s1097-2765(00)80073-8

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  13 in total

1.  Vaccinia topoisomerase and Cre recombinase catalyze direct ligation of activated DNA substrates containing a 3'-para-nitrophenyl phosphate ester.

Authors:  G Woodfield; C Cheng; S Shuman; A B Burgin
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

2.  Novel mechanism of RNA repair by RtcB via sequential 2',3'-cyclic phosphodiesterase and 3'-Phosphate/5'-hydroxyl ligation reactions.

Authors:  Naoko Tanaka; Anupam K Chakravarty; Bill Maughan; Stewart Shuman
Journal:  J Biol Chem       Date:  2011-10-31       Impact factor: 5.157

3.  Unmasking Anticooperative DNA-binding interactions of vaccinia DNA topoisomerase I.

Authors:  Rajesh Nagarajan; James T Stivers
Journal:  Biochemistry       Date:  2007-01-09       Impact factor: 3.162

Review 4.  Recognition and repair of chemically heterogeneous structures at DNA ends.

Authors:  Sara N Andres; Matthew J Schellenberg; Bret D Wallace; Percy Tumbale; R Scott Williams
Journal:  Environ Mol Mutagen       Date:  2014-08-11       Impact factor: 3.216

5.  Topoisomerase I alone is sufficient to produce short DNA deletions and can also reverse nicks at ribonucleotide sites.

Authors:  Shar-Yin Naomi Huang; Sanchari Ghosh; Yves Pommier
Journal:  J Biol Chem       Date:  2015-04-17       Impact factor: 5.157

6.  A poxvirus-like type IB topoisomerase family in bacteria.

Authors:  Berit Olsen Krogh; Stewart Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

Review 7.  The Top1 paradox: Friend and foe of the eukaryotic genome.

Authors:  Nayun Kim; Sue Jinks-Robertson
Journal:  DNA Repair (Amst)       Date:  2017-06-09

8.  Toprim--a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins.

Authors:  L Aravind; D D Leipe; E V Koonin
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

9.  Chemical mutagenesis of vaccinia DNA topoisomerase lysine 167 provides insights to the catalysis of DNA transesterification.

Authors:  Lyudmila Yakovleva; Stewart Shuman
Journal:  Biochemistry       Date:  2013-01-23       Impact factor: 3.162

10.  Parallel analysis of ribonucleotide-dependent deletions produced by yeast Top1 in vitro and in vivo.

Authors:  Jang-Eun Cho; Shar-Yin N Huang; Peter M Burgers; Stewart Shuman; Yves Pommier; Sue Jinks-Robertson
Journal:  Nucleic Acids Res       Date:  2016-06-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.